New biomarker for acute ischaemic stroke: plasma glycogen phosphorylase isoenzyme BB

Abstract

GPBB demonstrates robust response to acute ischaemia and high sensitivity for small infarcts. If confirmed in more diverse populations that also include stroke mimics, GPBB could find utility as a stand-alone marker for acute brain ischaemia.